David Ratzman, M.D.
Interventional Pain Medicine Physician in Indianapolis, Indiana.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,603 in Interventional Pain Medicine Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
David Ratzman, M.D. reported a CMS MIPS final score of 97.6/100 - above the 83.5 national average - and filed 1,901 Medicare Part D claims in 2024.
- 97.6/100
- MIPS score · +14 vs avg
- 2K
- Part D claims, 2024
- 89%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about David Ratzman, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1174528152), first enumerated 06/16/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,901 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 97.6/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
3 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1174528152 · Interventional Pain Medicine Physician
NPI-10 · ENUM-LEGACY · TAX-NARROW · MIPS-ELITE · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1174528152
- ENUM-LEGACY 2005
- TAX-NARROW 1,603
- MIPS-ELITE 97.6/100
- RX-MID 1,901
- BOOK-THIN 43 in Indiana
- PHOTO-FINISH George Girardi · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Ratzman · this p…
Ratzman · this provider
97.6 MIPS pts
- Adam Siwek · hig…
Adam Siwek
97.6 MIPS pts
- George Girardi ·…
George Girardi
97.6 MIPS pts
- Craig Nairn · near
Craig Nairn
97.6 MIPS pts
- Maria Vanushkina…
Maria Vanushkina
97.6 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
David Ratzman, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
98 ≥ 84th percentile 84% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where David Ratzman, M.D. sits
This provider among interventional pain medicine physician peers
Across the 446 interventional pain medicine physician providers who report both Medicare Part D prescribing and a MIPS quality score, David Ratzman, M.D. writes more Part D claims than 56% of them and scores higher on MIPS quality than 84% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one interventional pain medicine physician peer from a representative sample of 60; the gold marker is David Ratzman, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
David Ratzman, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 3 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about David Ratzman, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Indiana
How Interventional Pain Medicine Physician compares to other specialties among Indiana providers
Interventional Pain Medicine Physician ranks #165 among Indiana's specialties (0% of in-state providers)
Each bar is a specialty's share of the Indiana provider total, by primary NUCC taxonomy. The highlighted bar is Interventional Pain Medicine Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
David Ratzman, M.D.'s 2023 MIPS final score plotted against the Interventional Pain Medicine Physician national average
- MIPS Final Score
- 97.6/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Specialty volume Interventional Pain Medicine Physician US NPIs
97.6/100 MIPS final score - 14.1 pts above the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Interventional Pain Medicine Physician. Quality dim: 86.5.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1174528152 |
|---|---|
| Specialty | Interventional Pain Medicine Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/16/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm David Ratzman, M.D.'s current license status, disciplinary history, and board certifications with the Indiana Medical Licensing Board in Indiana before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1174528152 is the unique 10-digit identifier CMS uses to link Ratzman across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where David Ratzman, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
According to CMS billing records, David Ratzman, M.D. is affiliated with 3 Medicare-billing facilities.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Typical
11% brand-name claims vs 89% generic, on 1,901 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 2,199.2
- Total Day Supply
- 53,401
- Brand vs Generic
- 11% brand / 89% generic
- Brand Drug Cost
- $194K
- Generic Drug Cost
- $51K
- Opioid Claims
- 1,109 (58.3% rate)
Patient Demographics
- Average Patient Age
- 73.6 years
- Avg HCC Risk Score
- 1.59
- Gender Split
- 68% female / 32% male
- Age Distribution
- <65: 26, 65-74: 70, 75-84: 75, 85+: 19
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What David Ratzman, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Hydrocodone-Acetam…
Hydrocodone-Acetaminophen
524 claims
- Gabapentin
Gabapentin
332 claims
- Pregabalin 103
Pregabalin
103 claims
- Tramadol Hcl 97
Tramadol Hcl
97 claims
- Oxycodone Hcl 89
Oxycodone Hcl
89 claims
- Oxycodone-Acetamin… 88
Oxycodone-Acetaminophen
88 claims
- Cyclobenzaprine Hcl 83
Cyclobenzaprine Hcl
83 claims
- Hysingla Er 53
Hysingla Er
53 claims
| Drug | Claims |
|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 524 |
| Gabapentin | 332 |
| Pregabalin | 103 |
| Tramadol Hcl | 97 |
| Oxycodone Hcl | 89 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 88 |
| Cyclobenzaprine Hcl | 83 |
| Hysingla Er Hydrocodone Bitartrate | 53 |
| Fentanyl | 42 |
| Morphine Sulfate | 36 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Interventional Pain Medicine Physician Overview
How David Ratzman, M.D. fits within the Interventional Pain Medicine Physician landscape nationally.
David Ratzman, M.D.'s 1,901 claims are below the specialty average of 2,221.
Nationwide Interventional Pain Medicine Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Ratzman, both outside Indiana so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (97.6 here).
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Interventional Pain Medicine Physician Providers in Indiana
Other clinicians with the same primary specialty enrolled in Indiana, drawn from the same CMS NPPES roster as Ratzman.
One of 43 Interventional Pain Medicine Physician providers enrolled in Indiana, 5 are shown here.
Compare Interventional Pain Medicine Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is David Ratzman, M.D.'s specialty? ▼
How much does David Ratzman, M.D. prescribe under Medicare Part D? ▼
What is David Ratzman, M.D.'s Medicare quality score? ▼
Where is David Ratzman, M.D. located? ▼
What is David Ratzman, M.D.'s NPI number? ▼
Does David Ratzman, M.D. prescribe more brand-name or generic drugs? ▼
Does David Ratzman, M.D. prescribe opioids? ▼
How many Interventional Pain Medicine Physician providers are there in the US? ▼
What drugs does David Ratzman, M.D. prescribe most often? ▼
Does David Ratzman, M.D. accept Medicare? ▼
How can I verify David Ratzman, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.